TubeRank
MRNABullunverifiable
Randy KirkRandy Kirk
Madna you know had a double almost a triple on their stock and could go even higher right that being able to win on AI applied to medicine healthcare is going to be I think a huge ahead of the actual development.

Thesis at the time

Bullish

The hosts discuss Moderna's mRNA cancer treatment breakthrough that reduced high-risk cancer recurrence, noting the stock roughly doubled to tripled on the news. They frame this as the start of a broader 'ChatGPT moment' for AI applied to medicine that could pull in massive R&D investment from big pharma.

Key arguments

  • Moderna's phase 3 trial showed a significant reduction in high-risk cancer recurrence using personalized mRNA treatment
  • The stock roughly doubled/tripled on the announcement, implying a jump from a $50B to $100-120B market cap
  • AI applied to medicine (imaging, biomarkers, drug design) could trigger a 'gold rush' and accelerate cures beyond current timelines
  • Big pharma players like Roche/Genentech and Eli Lilly are only using a small fraction of available AI compute so far, implying room for growth

Counter-arguments acknowledged

  • The treatment reduces cancer recurrence risk rather than being an outright 'cure'
  • Current compute usage by big pharma is still tiny relative to AI infrastructure, so gains may take time to materialize

Hedges and caveats (from the video)

  • Treatment reduces recurrence risk by 49%, not a cure
  • Results based on high-risk population, not general population
  • Clinical trials took 5+ years to complete
  • Further improvements and applications still being developed
  • Host explicitly states he was not in the stock before the announcement

The call

Date said
Aug 20, 2026
Confidence
low
Specificity
vague

How it resolved

Status
unverifiable
Why this resolved this way(resolution audit)
Reference price
(anchored at quote date)
Target used
Deadline source
None — neither explicit nor horizon-derived
Age at resolution
1.1 months(from publish date)

Full rules: docs/resolution-spec.md.

Confidence Reasoning

Hedge word 'could' weakens an otherwise bullish continuation call, and no specific target or timeframe is given.